BACKGROUND AND METHODS. Toxoplasmosis is the most common opportunistic infection of the central nervous system in patients with the acquired immunodeficiency syndrome (AIDS). To investigate its clinical course, we reviewed the records of 115 patients with AIDS and central nervous system toxoplasmosis treated at San Francisco General Hospital between 1981 and 1990. RESULTS. The most common presenting symptoms were headache (in 55 percent), confusion (52 percent), and fever (47 percent). Focal neurologic deficits were present in 79 patients (69 percent). The median CD4 cell count at presentation was 50 per cubic millimeter (50 x 10(6) per liter). Thirteen of 80 patients with clinical toxoplasmosis (16 percent) and 4 of 18 patients with pathologically proved disease (22 percent) had undetectable antitoxoplasma IgG antibodies by indirect immunofluorescence assay. Of 103 patients, 94 (91 percent) had enhancing lesions on CT. Single lesions were seen in 28 of 103 patients (27 percent) on CT, and such lesions were seen in 3 of 21 patients (14 percent) on magnetic resonance imaging. Over 90 percent of patients who eventually had clinical and radiographic improvement had evidence of improvement by day 14 of therapy. Adverse drug reactions occurred in 71 patients (62 percent) and led to a change in therapy in 50 patients (43 percent). Among the patients who survived a first episode of toxoplasmosis, the median survival was 265 days. CONCLUSIONS. Toxoplasmosis occurs in advanced stages of human immunodeficiency virus infection, and the absence of antitoxoplasma antibodies on immunofluorescence assay does not exclude the diagnosis. The clinical and radiographic response to therapy is usually rapid, but treatment is frequently limited by adverse drug effects.
Source Information
Medical Service, San Francisco General Hospital, CA 94110.
This article has been cited by other articles:
Pollard, A. M., Skariah, S., Mordue, D. G., Knoll, L. J.
(2009). A Transmembrane Domain-Containing Surface Protein from Toxoplasma gondii Augments Replication in Activated Immune Cells and Establishment of a Chronic Infection. Infect. Immun.
77: 3731-3739
[Abstract][Full Text]
Pfeffer, G., Prout, A., Hooge, J., Maguire, J.
(2009). BIOPSY-PROVEN IMMUNE RECONSTITUTION SYNDROME IN A PATIENT WITH AIDS AND CEREBRAL TOXOPLASMOSIS. Neurology
73: 321-322
[Full Text]
Lee, G. T., Antelo, F., Mlikotic, A. A.
(2009). Best Cases from the AFIP: Cerebral Toxoplasmosis1. RadioGraphics
29: 1200-1205
[Full Text]
Shubar, H. M., Mayer, J. P., Hopfenmuller, W., Liesenfeld, O.
(2008). A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo. J Antimicrob Chemother
61: 1110-1119
[Abstract][Full Text]
Kongsaengdao, S., Samintarapanya, K., Oranratnachai, K., Prapakarn, W., Apichartpiyakul, C.
(2008). Randomized Controlled Trial of Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients. J Int Assoc Physicians AIDS Care (Chic Ill)
7: 11-16
[Abstract]
Kumar, R., Basu, S., Torigian, D., Anand, V., Zhuang, H., Alavi, A.
(2008). Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography. Clin. Microbiol. Rev.
21: 209-224
[Abstract][Full Text]
Martins-Duarte, E. S., Urbina, J. A., de Souza, W., Vommaro, R. C.
(2006). Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro. J Antimicrob Chemother
58: 59-65
[Abstract][Full Text]
Dunay, I. R., Heimesaat, M. M., Bushrab, F. N., Muller, R. H., Stocker, H., Arasteh, K., Kurowski, M., Fitzner, R., Borner, K., Liesenfeld, O.
(2004). Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated Toxoplasmosis. Antimicrob. Agents Chemother.
48: 4848-4854
[Abstract][Full Text]
Ionita, C., Wasay, M., Balos, L., Bakshi, R.
(2004). MR Imaging in Toxoplasmosis Encephalitis after Bone Marrow Transplantation: Paucity of Enhancement despite Fulminant Disease. Am. J. Neuroradiol.
25: 270-273
[Abstract][Full Text]
Berger, J. R.
(2003). Mass Lesions of the Brain in AIDS: The Dilemmas of Distinguishing Toxoplasmosis from Primary CNS Lymphoma. Am. J. Neuroradiol.
24: 554-555
[Full Text]
Wei, S., Marches, F., Borvak, J., Zou, W., Channon, J., White, M., Radke, J., Cesbron-Delauw, M.-F., Curiel, T. J.
(2002). Toxoplasma gondii-Infected Human Myeloid Dendritic Cells Induce T-Lymphocyte Dysfunction and Contact-Dependent Apoptosis. Infect. Immun.
70: 1750-1760
[Abstract][Full Text]
Giraldo, M., Portela, R. W. D., Snege, M., Leser, P. G., Camargo, M. E., Mineo, J. R., Gazzinelli, R. T.
(2002). Immunoglobulin M (IgM)-Glycoinositolphospholipid Enzyme-Linked Immunosorbent Assay: an Immunoenzymatic Assay for Discrimination between Patients with Acute Toxoplasmosis and Those with Persistent Parasite-Specific IgM Antibodies. J. Clin. Microbiol.
40: 1400-1405
[Abstract][Full Text]
Sibtain, N A, Chinn, R J S
(2002). Imaging of the central nervous system in HIV infection. Imaging
14: 48-59
[Abstract][Full Text]
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H., Liesenfeld, O.
(2001). Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis. Antimicrob. Agents Chemother.
45: 1771-1779
[Abstract][Full Text]
Purdy, B. D.
(2000). Management and Prevention of Opportunistic Infections in the HIV-Infected Patient. Journal of Pharmacy Practice
13: 475-498
[Abstract]
Lin, M.-H., Chen, T.-C., Kuo, T.-t., Tseng, C.-C., Tseng, C.-P.
(2000). Real-Time PCR for Quantitative Detection of Toxoplasma gondii. J. Clin. Microbiol.
38: 4121-4125
[Abstract][Full Text]
Cabre, P, Smadja, D, Cabié, A, Newton, C R J C
(2000). NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: HTLV-1 and HIV infections of the central nervous system in tropical areas. J. Neurol. Neurosurg. Psychiatry
68: 550-557
[Full Text]
Giraldo, M., Cannizzaro, H., Ferguson, M. A. J., Almeida, I. C., Gazzinelli, R. T.
(2000). Fractionation of Membrane Components from Tachyzoite Forms of Toxoplasma gondii: Differential Recognition by Immunoglobulin M (IgM) and IgG Present in Sera from Patients with Acute or Chronic Toxoplasmosis. J. Clin. Microbiol.
38: 1453-1460
[Abstract][Full Text]
Graham III, C. B., Wippold II, F. J., Pilgram, T. K., Fisher, E. J., Smoker, W. R. K.
(2000). Screening CT of the Brain Determined by CD4 Count in HIV-Positive Patients Presenting with Headache. Am. J. Neuroradiol.
21: 451-454
[Abstract][Full Text]
Taylor, G. A., Collazo, C. M., Yap, G. S., Nguyen, K., Gregorio, T. A., Taylor, L. S., Eagleson, B., Secrest, L., Southon, E. A., Reid, S. W., Tessarollo, L., Bray, M., McVicar, D. W., Komschlies, K. L., Young, H. A., Biron, C. A., Sher, A., Vande Woude, G. F.
(2000). Pathogen-specific loss of host resistance in mice lacking the IFN-gamma -inducible gene IGTP. Proc. Natl. Acad. Sci. USA
97: 751-755
[Abstract][Full Text]
Reichmann, G., Villegas, E. N., Craig, L., Peach, R., Hunter, C. A.
(1999). The CD28/B7 Interaction Is Not Required for Resistance to Toxoplasma gondii in the Brain but Contributes to the Development of Immunopathology. J. Immunol.
163: 3354-3362
[Abstract][Full Text]
Wallon, M., Liou, C., Garner, P., Peyron, F.
(1999). Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ
318: 1511-1514
[Abstract][Full Text]
Rivero, M. E., Kuppermann, B. D., Wiley, C. A., Garcia, C. R., Smith, M. D., Dreilinger, A., Freeman, W. R.
(1999). Acquired Immunodeficiency Syndrome-Related Intraocular B-Cell Lymphoma. Arch Ophthalmol
117: 616-622
[Abstract][Full Text]
Lee, V. W., Antonacci, V., Tilak, S., Fuller, J. D., Cooley, T. P.
(1999). Intracranial Mass Lesions: Sequential Thallium and Gallium Scintigraphy in Patients with AIDS. Radiology
211: 507-512
[Abstract][Full Text]
Ronthal, M., Vonsattel, J.-P.
(1995). Case 33-1995- Progressive neurologic deterioration with unusual findings on magnetic resonance imaging in a 43-year-old man treated for demyelinating disease. NEJM
333: 1135-1143
[Full Text]
Czachor, J. S., Gleckman, R. A.
(1995). Selective Causes of Fever in Adult Human Immunodeficiency Virus--Infected Patients Relative to CD4+ Cell Counts. Arch Fam Med
4: 879-884
[Abstract]
Basgoz, N., Mattia, A. R.
(1994). Case 4-1994- A 38-Year-Old Man with AIDS and the Recent Onset of Diarrhea, Hematochezia, Fever, and Pulmonary Infiltrates. NEJM
330: 273-280
[Full Text]
Paddock, C. D., Suchard, D. P., Grumbach, K. L., Hadley, W. K., Kerschmann, R. L., Abbey, N. W., Dawson, J. E., Anderson, B. E., Sims, K. G., Dumler, J. S., Herndier, B. G.
(1993). Fatal Seronegative Ehrlichiosis in a Patient with HIV Infection. NEJM
329: 1164-1167
[Full Text]
Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D., Uttamchandani, R., Fuhrer, J., Jacobson, J., Morlat, P., Vilde, J.-L., Remington, J. S.
(1993). Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome. NEJM
329: 995-1000
[Abstract][Full Text]
Klein, R. S., Manian, F. A., LaRocco, A., Sanders, J. W., Myers, J. W., Bretagne, S., Gray, F., Costa, J.-M., Porter, S. B., Sande, M. A.
(1993). Central Nervous System Toxoplasmosis in AIDS. NEJM
328: 1352-1354
[Full Text]
(1992). NOTES ON CEREBRAL TOXOPLASMOSIS IN AIDS. JWatch General
1992: 5-5
[Full Text]
Previous
